EGFR-IN-31
EGFR-IN-31 is a potent inhibitor of EGFR. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-31 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185298A1, compound 2).
For research use only. We do not sell to patients.
- CAS No.: 2701563-03-1
- Formula: C32H36FN7O2
- Molecular Weight:569.67
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All EGFR Isoforms
More
Biological Activity
Chemical Information
-
CAS No. 2701563-03-1
-
Molecular Weight 569.67
-
Formula C32H36FN7O2
-
SMILES
O=C(NC1=CC(NC2=NC(NC3=CC=C(C)C=C3)=C(C4=CC=C(C=C4)F)C=N2)=C(C=C1N(CCN(C)C)C)OC)C=C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)